North America Prescription Digital Therapeutics Dtx Market Analysis

Pharmaceutical
Upcoming Report
Feb 2023
North America
350 Pages
No of Tables: 220
No of Figures: 60

Buy Now

Frequently Asked Questions

At what growth rate will the market be projected to grow during the forecast period of 2023 to 2030?

The North America Prescription Digital Therapeutics (PDTx) Market is projected to grow at a CAGR of 22.0% during the forecast period by 2030.

What will be the market value in the future?

The future market value of the North America Prescription Digital Therapeutics (PDTx) Market is expected to reach USD 3688.53 million by 2030.

Who are the major players operating in the market?

The major players in the North America Prescription Digital Therapeutics (PDTx) Market are ResMed (U.S.), SAMSUNGHEALTHCARE (South Korea), Biofourmis (U.S.), Novartis AG (Switzerland), Medtronic (Ireland), Pear Therapeutics, Inc. (U.S.), Voluntis (France), Omada Health, Inc. (U.S.), etc.

Which countries data are covered in the report?

The countries covered in the North America Prescription Digital Therapeutics (PDTx) Market are U.S., Canada and Mexico in North America.